Nebenwirkungen · Docetaxel Kabi
DOCETAXEL KABI 80 mg/4 ml concentrate for solution for infusion · Abschnitt 4.8 · PDF-Seite 75–76
HOS-214738 · Präparat HOS-155350
75 General disorders and administration site conditions Radiation recall phenomena have rarely been reported. Injection site recall reaction (recurrence of skin reaction at a site of previous extravasation following administration of docetaxel at a different site) has been observed at the site of previous extravasation (frequency not known). Fluid retention has not been accompanied by acute episodes of oliguria or hypotension. Dehydration and pulmonary oedema have rarely been reported.
Originalpassage; keine automatisch abgeleitete Schwere, Häufigkeit oder Kausalität. Auch verneinte Befunde und nicht untersuchte Kombinationen bleiben sichtbar.
Vollständigen Kontext in der EMA-Fachinformation lesen →Quellennachweis
Version 2025-08-04T15:44:00Z · SHA-256 4ec115d98d201d84de2340a9fdabdd8a6db17b0a20954d72cafab8a7e3eaf6e6 · Passage e490471e12c5203c6e42ef7008e251d23ba8c2fb0832fc882f396b7519d037ed · Zeichen 52684–53175 im Abschnitt